These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28456567)
1. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells. Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Reiter C; Capcı Karagöz A; Fröhlich T; Klein V; Zeino M; Viertel K; Held J; Mordmüller B; Emirdağ Öztürk S; Anıl H; Efferth T; Tsogoeva SB Eur J Med Chem; 2014 Mar; 75():403-12. PubMed ID: 24561670 [TBL] [Abstract][Full Text] [Related]
3. New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells. Reiter C; Herrmann A; Çapci A; Efferth T; Tsogoeva SB Bioorg Med Chem; 2012 Sep; 20(18):5637-41. PubMed ID: 22884578 [TBL] [Abstract][Full Text] [Related]
4. Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. Reiter C; Fröhlich T; Gruber L; Hutterer C; Marschall M; Voigtländer C; Friedrich O; Kappes B; Efferth T; Tsogoeva SB Bioorg Med Chem; 2015 Sep; 23(17):5452-8. PubMed ID: 26260339 [TBL] [Abstract][Full Text] [Related]
5. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Reiter C; Fröhlich T; Zeino M; Marschall M; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Hampel F; Efferth T; Tsogoeva SB Eur J Med Chem; 2015 Jun; 97():164-72. PubMed ID: 25965779 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Cytotoxicity of Diarylpentanoids against Sensitive CCRF-CEM and Multidrug-Resistant CEM/ADR5000 Leukemia Cells. Di Chio C; Zhou M; Efferth T; Schirmeister T; Zappalà M; Ettari R Chem Biodivers; 2022 Feb; 19(2):e202100451. PubMed ID: 34871465 [TBL] [Abstract][Full Text] [Related]
7. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Cytotoxicity of Thieno[2,3-b]Pyridine Derivatives Toward Sensitive and Multidrug-Resistant Leukemia Cells. Al-Trawneh SA; Tarawneh AH; Gadetskaya AV; Seo EJ; Al-Ta'ani MR; Al-Taweel SA; El-Abadelah MM Acta Chim Slov; 2021 Jun; 68(2):458-465. PubMed ID: 34738114 [TBL] [Abstract][Full Text] [Related]
9. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines. Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction. Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623 [TBL] [Abstract][Full Text] [Related]
11. Artemisinin-derived hybrids and their anticancer activity. Gao F; Sun Z; Kong F; Xiao J Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C). Koneru PB; Lien EJ; Avramis VI Pharm Res; 1993 Apr; 10(4):515-20. PubMed ID: 8483833 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells. Horwedel C; Tsogoeva SB; Wei S; Efferth T J Med Chem; 2010 Jul; 53(13):4842-8. PubMed ID: 20527917 [TBL] [Abstract][Full Text] [Related]
14. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities. Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055 [TBL] [Abstract][Full Text] [Related]
15. Activity-guided isolation of scopoletin and isoscopoletin, the inhibitory active principles towards CCRF-CEM leukaemia cells and multi-drug resistant CEM/ADR5000 cells, from Artemisia argyi. Adams M; Efferth T; Bauer R Planta Med; 2006 Jul; 72(9):862-4. PubMed ID: 16881019 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells. Kuete V; Sandjo LP; Seukep JA; Zeino M; Mbaveng AT; Ngadjui B; Efferth T Planta Med; 2015 Jan; 81(1):32-8. PubMed ID: 25473921 [TBL] [Abstract][Full Text] [Related]
17. 8,8-bis-(Dihydroconiferyl)-diferulate displayed impressive cytotoxicity towards a panel of human and animal cancer cells. Mbaveng AT; Damen F; Guefack MF; Tankeo SB; Abdelfatah S; Bitchagno GTM; Çelik İ; Kuete V; Efferth T Phytomedicine; 2020 Apr; 70():153215. PubMed ID: 32388040 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids. Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158 [TBL] [Abstract][Full Text] [Related]
19. Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug resistant CCRF-CEM leukemia cells. Zhou M; Boulos JC; Omer EA; Rudbari HA; Schirmeister T; Micale N; Efferth T Eur J Pharmacol; 2023 Oct; 956():175980. PubMed ID: 37567459 [TBL] [Abstract][Full Text] [Related]